Page 24 - John Jacobs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Novavax reported revenue of $187 million for the quarter, down from $734.58 million a year ago, but above analysts' expectations of $158.5 million, according to LSEG data. "We've really optimized that U.S. grant opportunity, which was something that was uncertain at the beginning of the year," Novavax CEO John Jacobs said in an interview, adding that the government had shortened the timeline for being able to tap into those funds. The Maryland-based biotech has flagged concerns about its ability to remain in business and has been banking on cost cuts and commercial sales ...

Novavax Inc NVAX reported Q3 revenue of $187 million, compared to $735 million in the same period in 2022, beating the consensus of $158.54 million. "We've…

Gaithersburg, Maryland-based COVID-19 vaccine maker Novavax saw its third quarter revenue tumble and it may further reduce expenses by millions of dollars.

By Patrick Wingrove and Bhanvi Satija (Reuters) -COVID-19 vaccine maker Novavax on Thursday beat market estimates for quarterly revenue, boosted by U.S.

The hearing of further evidence from witnesses in the murder trial involving Portland businessman Everton 'Beachy Stout' McDonald has been put on hold until next Tuesday to facilitate a voir dire – trial within a trial.  ...